Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 637 to 643 of 643 entries
Sorted by: Best Match Show Resources per page
Biomechanical analysis of a centralization procedure for extruded lateral meniscus after meniscectomy in porcine knee joints.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society

Kohno Y, Koga H, Ozeki N, Matsuda J, Mizuno M, Katano H, Sekiya I.
PMID: 34314533
J Orthop Res. 2021 Jul 27; doi: 10.1002/jor.25146. Epub 2021 Jul 27.

The recently developed arthroscopic centralization for lateral meniscal extrusion has obtained satisfactory short-term clinical and radiological results and improves the meniscus biomechanical properties. However, the effectiveness of treatment for meniscus extrusion after partial meniscectomy still requires elucidation. This study...

Cite
Kohno Y, Koga H, Ozeki N, et al. Biomechanical analysis of a centralization procedure for extruded lateral meniscus after meniscectomy in porcine knee joints. J Orthop Res. 2021;doi: 10.1002/jor.25146.
Kohno, Y., Koga, H., Ozeki, N., Matsuda, J., Mizuno, M., Katano, H., & Sekiya, I. (2021). Biomechanical analysis of a centralization procedure for extruded lateral meniscus after meniscectomy in porcine knee joints. Journal of orthopaedic research : official publication of the Orthopaedic Research Society, . https://doi.org/10.1002/jor.25146
Kohno, Yuji, et al. "Biomechanical analysis of a centralization procedure for extruded lateral meniscus after meniscectomy in porcine knee joints." Journal of orthopaedic research : official publication of the Orthopaedic Research Society vol. (2021). doi: https://doi.org/10.1002/jor.25146
Kohno Y, Koga H, Ozeki N, Matsuda J, Mizuno M, Katano H, Sekiya I. Biomechanical analysis of a centralization procedure for extruded lateral meniscus after meniscectomy in porcine knee joints. J Orthop Res. 2021 Jul 27; doi: 10.1002/jor.25146. Epub 2021 Jul 27. PMID: 34314533.
Copy Download .nbib Format: NLM
Greater arterial wall viscosity in endurance-trained men.

European journal of applied physiology

Kawano H, Asaka M, Yamamoto K, Gando Y, Konishi M, Sakamoto S, Miyachi M, Higuchi M.
PMID: 33890159
Eur J Appl Physiol. 2021 Aug;121(8):2219-2228. doi: 10.1007/s00421-021-04686-5. Epub 2021 Apr 23.

PURPOSE: The age-associated increase in arterial wall viscosity (AWV) is attenuated by high cardiorespiratory fitness level. However, AWV in endurance-trained athletes have not been determined. We designed a cross sectional study to compare central AWV and compliance between endurance-trained...

Cite
Kawano H, Asaka M, Yamamoto K, et al. Greater arterial wall viscosity in endurance-trained men. Eur J Appl Physiol. 2021;121(8):2219-2228doi: 10.1007/s00421-021-04686-5.
Kawano, H., Asaka, M., Yamamoto, K., Gando, Y., Konishi, M., Sakamoto, S., Miyachi, M., & Higuchi, M. (2021). Greater arterial wall viscosity in endurance-trained men. European journal of applied physiology, 121(8), 2219-2228. https://doi.org/10.1007/s00421-021-04686-5
Kawano, Hiroshi, et al. "Greater arterial wall viscosity in endurance-trained men." European journal of applied physiology vol. 121,8 (2021): 2219-2228. doi: https://doi.org/10.1007/s00421-021-04686-5
Kawano H, Asaka M, Yamamoto K, Gando Y, Konishi M, Sakamoto S, Miyachi M, Higuchi M. Greater arterial wall viscosity in endurance-trained men. Eur J Appl Physiol. 2021 Aug;121(8):2219-2228. doi: 10.1007/s00421-021-04686-5. Epub 2021 Apr 23. PMID: 33890159.
Copy Download .nbib Format: NLM
Complete Genome Sequence of Carp Edema Virus Isolated from Koi Carp.

Microbiology resource announcements

Mekata T, Kawato Y, Ito T.
PMID: 33888504
Microbiol Resour Announc. 2021 Apr 22;10(16). doi: 10.1128/MRA.00239-21.

Carp edema virus disease (CEVD), or koi sleepy disease, is caused by CEV. Here, we report the complete genome sequence of CEV strain FTI2020, isolated from koi carp. This sequence information has great potential for improving our understanding of...

Cite
Mekata T, Kawato Y, Ito T. Complete Genome Sequence of Carp Edema Virus Isolated from Koi Carp. Microbiol Resour Announc. 2021;10(16)doi: 10.1128/MRA.00239-21.
Mekata, T., Kawato, Y., & Ito, T. (2021). Complete Genome Sequence of Carp Edema Virus Isolated from Koi Carp. Microbiology resource announcements, 10(16), . https://doi.org/10.1128/MRA.00239-21
Mekata, Tohru, et al. "Complete Genome Sequence of Carp Edema Virus Isolated from Koi Carp." Microbiology resource announcements vol. 10,16 (2021). doi: https://doi.org/10.1128/MRA.00239-21
Mekata T, Kawato Y, Ito T. Complete Genome Sequence of Carp Edema Virus Isolated from Koi Carp. Microbiol Resour Announc. 2021 Apr 22;10(16). doi: 10.1128/MRA.00239-21. PMID: 33888504; PMCID: PMC8063647.
Copy Download .nbib Format: NLM
Evaluation of synchronous multiple primary superficial laryngo-pharyngeal cancers that were treated by endoscopic laryngo-pharyngeal surgery.

Auris, nasus, larynx

Ohno K, Kawada K, Sugimoto T, Kiyokawa Y, Kawabe H, Takahashi R, Koide N, Tateishi Y, Tasaki A, Ariizumi Y, Asakage T.
PMID: 33892989
Auris Nasus Larynx. 2021 Dec;48(6):1162-1166. doi: 10.1016/j.anl.2021.03.022. Epub 2021 Apr 21.

OBJECTIVE: ndoscopic laryngopharyngeal surgery (ELPS) is a useful surgery for superficial cancers of the head and neck region, but it has not yet been well evaluated for synchronous multiple primary cancers (multiple primaries). The purpose of this study was...

Cite
Ohno K, Kawada K, Sugimoto T, et al. Evaluation of synchronous multiple primary superficial laryngo-pharyngeal cancers that were treated by endoscopic laryngo-pharyngeal surgery. Auris Nasus Larynx. 2021;48(6):1162-1166doi: 10.1016/j.anl.2021.03.022.
Ohno, K., Kawada, K., Sugimoto, T., Kiyokawa, Y., Kawabe, H., Takahashi, R., Koide, N., Tateishi, Y., Tasaki, A., Ariizumi, Y., & Asakage, T. (2021). Evaluation of synchronous multiple primary superficial laryngo-pharyngeal cancers that were treated by endoscopic laryngo-pharyngeal surgery. Auris, nasus, larynx, 48(6), 1162-1166. https://doi.org/10.1016/j.anl.2021.03.022
Ohno, Kazuchika, et al. "Evaluation of synchronous multiple primary superficial laryngo-pharyngeal cancers that were treated by endoscopic laryngo-pharyngeal surgery." Auris, nasus, larynx vol. 48,6 (2021): 1162-1166. doi: https://doi.org/10.1016/j.anl.2021.03.022
Ohno K, Kawada K, Sugimoto T, Kiyokawa Y, Kawabe H, Takahashi R, Koide N, Tateishi Y, Tasaki A, Ariizumi Y, Asakage T. Evaluation of synchronous multiple primary superficial laryngo-pharyngeal cancers that were treated by endoscopic laryngo-pharyngeal surgery. Auris Nasus Larynx. 2021 Dec;48(6):1162-1166. doi: 10.1016/j.anl.2021.03.022. Epub 2021 Apr 21. PMID: 33892989.
Copy Download .nbib Format: NLM
Switching From Daily DPP-4 Inhibitor to Once-Weekly GLP-1 Receptor Activator Dulaglutide Significantly Ameliorates Glycemic Control in Subjects With Poorly Controlled Type 2 Diabetes Mellitus: A Retrospective Observational Study.

Frontiers in endocrinology

Sanada J, Kimura T, Shimoda M, Tomita A, Fushimi Y, Kinoshita T, Obata A, Okauchi S, Hirukawa H, Kohara K, Tatsumi F, Nakanishi S, Mune T, Kaku K, Kaneto H.
PMID: 34484124
Front Endocrinol (Lausanne). 2021 Aug 06;12:714447. doi: 10.3389/fendo.2021.714447. eCollection 2021.

AIM: At present, daily DPP-4 inhibitors are quite frequently prescribed in subjects with type 2 diabetes mellitus (T2DM). Recently, it has been drawing much attention that once-weekly incretin-based injection dulaglutide was developed. In this study, we aimed to examine...

Cite
Sanada J, Kimura T, Shimoda M, et al. Switching From Daily DPP-4 Inhibitor to Once-Weekly GLP-1 Receptor Activator Dulaglutide Significantly Ameliorates Glycemic Control in Subjects With Poorly Controlled Type 2 Diabetes Mellitus: A Retrospective Observational Study. Front Endocrinol (Lausanne). 2021;12:714447doi: 10.3389/fendo.2021.714447.
Sanada, J., Kimura, T., Shimoda, M., Tomita, A., Fushimi, Y., Kinoshita, T., Obata, A., Okauchi, S., Hirukawa, H., Kohara, K., Tatsumi, F., Nakanishi, S., Mune, T., Kaku, K., & Kaneto, H. (2021). Switching From Daily DPP-4 Inhibitor to Once-Weekly GLP-1 Receptor Activator Dulaglutide Significantly Ameliorates Glycemic Control in Subjects With Poorly Controlled Type 2 Diabetes Mellitus: A Retrospective Observational Study. Frontiers in endocrinology, 12714447. https://doi.org/10.3389/fendo.2021.714447
Sanada, Junpei, et al. "Switching From Daily DPP-4 Inhibitor to Once-Weekly GLP-1 Receptor Activator Dulaglutide Significantly Ameliorates Glycemic Control in Subjects With Poorly Controlled Type 2 Diabetes Mellitus: A Retrospective Observational Study." Frontiers in endocrinology vol. 12 (2021): 714447. doi: https://doi.org/10.3389/fendo.2021.714447
Sanada J, Kimura T, Shimoda M, Tomita A, Fushimi Y, Kinoshita T, Obata A, Okauchi S, Hirukawa H, Kohara K, Tatsumi F, Nakanishi S, Mune T, Kaku K, Kaneto H. Switching From Daily DPP-4 Inhibitor to Once-Weekly GLP-1 Receptor Activator Dulaglutide Significantly Ameliorates Glycemic Control in Subjects With Poorly Controlled Type 2 Diabetes Mellitus: A Retrospective Observational Study. Front Endocrinol (Lausanne). 2021 Aug 06;12:714447. doi: 10.3389/fendo.2021.714447. eCollection 2021. PMID: 34484124; PMCID: PMC8415741.
Copy Download .nbib Format: NLM
Yields of mesenchymal stromal cells from synovial fluid reflect those from synovium in patients with rheumatoid arthritis.

Tissue & cell

Kohno Y, Mizuno M, Endo K, Ozeki N, Katano H, Matsumoto M, Kaneko H, Takazawa Y, Koga H, Sekiya I.
PMID: 34998163
Tissue Cell. 2022 Jan 04;75:101727. doi: 10.1016/j.tice.2021.101727. Epub 2022 Jan 04.

The yield of primary synovial mesenchymal stromal cells (MSCs) from synovium of patients with rheumatoid arthritis (RA) is highly variable, but cell transplantation therapy with autologous synovial MSCs requires accurate prediction of the synovial MSC yield per synovium weight....

Cite
Kohno Y, Mizuno M, Endo K, et al. Yields of mesenchymal stromal cells from synovial fluid reflect those from synovium in patients with rheumatoid arthritis. Tissue Cell. 2022;75:101727doi: 10.1016/j.tice.2021.101727.
Kohno, Y., Mizuno, M., Endo, K., Ozeki, N., Katano, H., Matsumoto, M., Kaneko, H., Takazawa, Y., Koga, H., & Sekiya, I. (2022). Yields of mesenchymal stromal cells from synovial fluid reflect those from synovium in patients with rheumatoid arthritis. Tissue & cell, 75101727. https://doi.org/10.1016/j.tice.2021.101727
Kohno, Yuji, et al. "Yields of mesenchymal stromal cells from synovial fluid reflect those from synovium in patients with rheumatoid arthritis." Tissue & cell vol. 75 (2022): 101727. doi: https://doi.org/10.1016/j.tice.2021.101727
Kohno Y, Mizuno M, Endo K, Ozeki N, Katano H, Matsumoto M, Kaneko H, Takazawa Y, Koga H, Sekiya I. Yields of mesenchymal stromal cells from synovial fluid reflect those from synovium in patients with rheumatoid arthritis. Tissue Cell. 2022 Jan 04;75:101727. doi: 10.1016/j.tice.2021.101727. Epub 2022 Jan 04. PMID: 34998163.
Copy Download .nbib Format: NLM
Yields of mesenchymal stromal cells from synovial fluid reflect those from synovium in patients with rheumatoid arthritis.

Tissue & cell

Kohno Y, Mizuno M, Endo K, Ozeki N, Katano H, Matsumoto M, Kaneko H, Takazawa Y, Koga H, Sekiya I.
PMID: 34998163
Tissue Cell. 2022 Jan 04;75:101727. doi: 10.1016/j.tice.2021.101727. Epub 2022 Jan 04.

The yield of primary synovial mesenchymal stromal cells (MSCs) from synovium of patients with rheumatoid arthritis (RA) is highly variable, but cell transplantation therapy with autologous synovial MSCs requires accurate prediction of the synovial MSC yield per synovium weight....

Cite
Kohno Y, Mizuno M, Endo K, et al. Yields of mesenchymal stromal cells from synovial fluid reflect those from synovium in patients with rheumatoid arthritis. Tissue Cell. 2022;75:101727doi: 10.1016/j.tice.2021.101727.
Kohno, Y., Mizuno, M., Endo, K., Ozeki, N., Katano, H., Matsumoto, M., Kaneko, H., Takazawa, Y., Koga, H., & Sekiya, I. (2022). Yields of mesenchymal stromal cells from synovial fluid reflect those from synovium in patients with rheumatoid arthritis. Tissue & cell, 75101727. https://doi.org/10.1016/j.tice.2021.101727
Kohno, Yuji, et al. "Yields of mesenchymal stromal cells from synovial fluid reflect those from synovium in patients with rheumatoid arthritis." Tissue & cell vol. 75 (2022): 101727. doi: https://doi.org/10.1016/j.tice.2021.101727
Kohno Y, Mizuno M, Endo K, Ozeki N, Katano H, Matsumoto M, Kaneko H, Takazawa Y, Koga H, Sekiya I. Yields of mesenchymal stromal cells from synovial fluid reflect those from synovium in patients with rheumatoid arthritis. Tissue Cell. 2022 Jan 04;75:101727. doi: 10.1016/j.tice.2021.101727. Epub 2022 Jan 04. PMID: 34998163.
Copy Download .nbib Format: NLM
Showing 637 to 643 of 643 entries